Dana-Farber Cancer Institute: all 833 studies

Page 7 of 9. Open to participants first (121), then studies with results posted, then the rest; newest registration first within each.

• Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot InterventionCompletedNCT02287519Not applicable
• Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBMActive, not recruitingNCT02287428Phase 1
• Parental Decision-Making for Children With Relapsed NeuroblastomaActive, not recruitingNCT02282735
• A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer CareActive, not recruitingNCT02279004
• Impact of Cerebellar Mass Resection on Pain ProcessingCompletedNCT02261649
• Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate CancerCompletedNCT02207504Phase 1
• Healthy Directions After Lung Surgery PilotCompletedNCT02135211Not applicable
• A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid TumorsCompletedNCT02133625Phase 1
• A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer PatientsCompletedNCT02129686Not applicable
• Whole-Exome Sequencing (WES) of Cancer PatientsCompletedNCT02127359
• Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants PatientsCompletedNCT02119897Not applicable
• Study of Omalizumab as Adjuvant Therapy in Chemotherapy DesensitizationCompletedNCT02118987Phase 1
• Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AMLActive, not recruitingNCT02091245Phase 1
• Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)CompletedNCT02057432Not applicable
• PALBOCICLIB + PD-0325901 for NSCLC & Solid TumorsCompletedNCT02022982Phase 1
• Healthy Living After Cancer: Weight Management Pilot StudyCompletedNCT01978899Not applicable
• A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple MyelomaCompletedNCT01965353Phase 1
• RPFNA Assessment of Exercise Effect in Breast CancerCompletedNCT01961128Not applicable
• Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple MyelomaCompletedNCT01955395Not applicable
• Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-DiseaseActive, not recruitingNCT01937468Phase 1
• ARRY-380 + Trastuzuamab for Breast w/ Brain MetsCompletedNCT01921335Phase 1
• Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative ChemotherapyCompletedNCT01894451Early Phase 1
• A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell LymphomaTerminatedNCT01878708Early Phase 1
• iCAT for Recurrent/Refractory/HR Solid TumorsCompletedNCT01853345
• Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care NetworksCompletedNCT01844999Not applicable
• The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms TechnologyCompletedNCT01838564Not applicable
• Tivozanib + Gemcitabine in Metastatic RCCWithdrawnNCT01834183Phase 2
• NIR-Guided Sentinel Lymph-Node Mapping for Esophageal CancerCompletedNCT01808417Phase 1
• Clofarabine for Langerhans in PediWithdrawnNCT01796405Phase 2
• Serious Illness Communication ProjectCompletedNCT01786811Not applicable
• Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck CancerCompletedNCT01783587Phase 1
• INHERIT EGFR - Studying Germline EGFR MutationsActive, not recruitingNCT01754025
• Dendritic Cell Activating Scaffold in MelanomaCompletedNCT01753089Phase 1
• BKM120+Abiraterone Acetate for Metastatic CRPCTerminatedNCT01741753Phase 1
• Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino ChurchesCompletedNCT01740219Not applicable
• Cisplatin + RT for Triple Negative Breast CancerCompletedNCT01674842Phase 1
• Ferumoxytol-Enhanced MRI in Adult/Pedi SarcomasWithdrawnNCT01663090Not applicable
• Olaparib for Patients With Recurrent BRCA Deficient Ovarian CancerWithdrawnNCT01661868Phase 2
• Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast CancerCompletedNCT01647607Not applicable
• Pilot Study for Young Women's InterventionCompletedNCT01647594Not applicable
• Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian CancerCompletedNCT01623349Phase 1
• OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the PancreasWithdrawnNCT01600807Phase 1/2
• Stereotactic Boost for Oropharyngeal Squamous Cell CarcinomaWithdrawnNCT01586182Phase 1/2
• XL-184+Abiraterone in Post-Chemo CRPCCompletedNCT01574937Phase 1
• Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision LumpectomyTerminatedNCT01568346Phase 3
• Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALLCompletedNCT01523977Phase 1
• The Preoperative Health & Body StudyActive, not recruitingNCT01516190Not applicable
• Socialization of Adult Men With Congenital Hemophilia A or BCompletedNCT01510418
• Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in VitroCompletedNCT01472627
• The Young Women's Breast Cancer StudyActive, not recruitingNCT01468246
• Multiple Risk Behavior Intervention in Health Care SettingsCompletedNCT01415492Not applicable
• SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)CompletedNCT01402687
• Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung CancerCompletedNCT01378598Not applicable
• Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD MethotrexateCompletedNCT01319591
• Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCTCompletedNCT01286675Early Phase 1
• MK-2206 for Recurrent Malignant GliomaWithdrawnNCT01249105Phase 2
• Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host DiseaseCompletedNCT01221766
• Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related DisordersActive, not recruitingNCT01177527
• NIR-Guided Sentinel Lymph Node Mapping in MelanomaCompletedNCT01121718Phase 1
• Panobinostat (LBH589) in Patients With Metastatic MelanomaCompletedNCT01065467Phase 1
• RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck CancerTerminatedNCT01058408Phase 1
• Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Gastrointestinal MalignanciesCompletedNCT00973440
• Observational Study of Iron Overload in Stem Cell TransplantationCompletedNCT00954720
• Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00942682Phase 1
• Skin Cancer Screening and Education at BeachesCompletedNCT00894855Not applicable
• Rapamycin in Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00874562Phase 1
• Computerized Assessment for Patients With CancerCompletedNCT00852852Not applicable
• Lung Cancer Symptom Assessment and Management InterventionCompletedNCT00852462Phase 2
• Prospective Analysis of Hypersensitivity Reactions to OxaliplatinCompletedNCT00831571
• Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)CompletedNCT00809588Phase 1
• Collection and Banking of Leukemia Cells MDS/AMLCompletedNCT00809367Not applicable
• Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell TransplantationCompletedNCT00809250Phase 1
• Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00804336Phase 1
• Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV MelanomaCompletedNCT00790010Phase 1
• Personal Patient Profile Prostate (P4) Randomized, Multisite TrialCompletedNCT00692653Not applicable
• Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic MalignanciesCompletedNCT00675831Phase 1
• Hypertension in Breast Cancer Patients Receiving BevacizumabTerminatedNCT00674011
• A Pilot Weight Control Intervention at HPHCCompletedNCT00644202Not applicable
• A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) TumorsTerminatedNCT00633958Phase 1
• A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer SurvivorsCompletedNCT00588107Not applicable
• Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
• The Active After Cancer Trial (AACT)Active, not recruitingNCT00548236Not applicable
• Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLLTerminatedNCT00543114Phase 1
• Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual FunctionCompletedNCT00525460
• Adoptive Transfer of MART1/Melan-A CTL for Malignant MelanomaCompletedNCT00512889Phase 1
• ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast CancerCompletedNCT00496665Phase 1
• Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical TrialsCompletedNCT00487513
• Vaccination for the Treatment of Previously Untreated or Relapsed Follicular LymphomaCompletedNCT00487305Phase 1
• Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia MajorCompletedNCT00480506
• Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic TransplantCompletedNCT00476177Phase 1
• Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or SurgeryTerminatedNCT00458549Not applicable
• Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by VaccinationCompletedNCT00442130Phase 1
• ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal CancerCompletedNCT00436072Phase 1
• Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal CarcinomaCompletedNCT00431210Phase 1
• Natural History Study of Patients With Chronic Myelogenous LeukemiaCompletedNCT00429910
• Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine GenerationCompletedNCT00428233Phase 1
• GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid MalignanciesCompletedNCT00426205Not applicable
• Pemetrexed in Patients With Advanced Neuroendocrine TumorsCompletedNCT00424723Phase 2
• Exercise Intervention in Women With Metastatic Breast CancerCompletedNCT00405782Not applicable
• C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00402545Phase 1

← Dana-Farber Cancer Institute overview and focus areas